Skip to main content

Edsard DeRoot

Analyst

Barclays

Equibles does not estimate personal net worth.

About Edsard DeRoot

Edsard DeRoot is recorded as Analyst at Barclays. Edsard DeRoot has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Syndax Pharmaceuticals Inc on August 4, 2026. Those appearances were for Syndax Pharmaceuticals Inc (SNDX), Exelixis, Inc. (EXEL) and Relay Therapeutics, Inc. (RLAY). The companies whose calls Edsard DeRoot spoke on are classified in the Healthcare sector.

Edsard DeRoot on recent calls

“A quick one for me, just wondering, for the proof of principle trial of REMU-MENIB in multiple fibrosis, what is the primary analysis, what will that entail, and what endpoints will you be evaluating there, just as a, you know, potential, obviously, read through to the next-gen MENIN inhibitor?”
Analyst — Barclays, Syndax Pharmaceuticals Inc Q2 FY2026 Earnings Call ·
“First, how are you thinking about how you're planning to leverage the non-LiverMet data from Cellar 303 given the December period of the date? Are you going to update your NDA to include that data?”
Analyst — Barclays, Exelixis Q1 2026 Financial Results Conference Call ·
“It's my pleasure to have our next fireside chat with Relay Therapeutics. With us this morning, we have Sanjay Patel, CEO of Relay, and Peter Rahmer, Chief Corporate and Development Officer.”
Analyst — Barclays, Barclays 28th Annual Global Healthcare Conference ·

Affiliation history

  • Barclays

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity